The effect of raloxifene in association with vitamin D on vaginal maturation index and urogenital symptoms in postmenopausal osteoporotic women

Hulusi Bülent Zeyneloğlu, Hulusi B. Zeyneloglu, Mesut Oktem, Mesut Öktem, Nihan A. Haberal, İbrahim Esinler, Esra Kuscu, Esra Kuşçu
Fertility and sterility · 2007 · vol. 88(2) , pp. 530–532 · doi:10.1016/j.fertnstert.2006.11.112 · PMID:17336964 · W2024435211
RCT OA: bronze CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Raloxifene and vitamin D treatment improved the vaginal maturation index and reduced urogenital symptoms in postmenopausal women with osteoporosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In elderly women with osteoporosis, raloxifene treatment with vitamin D supplementation improves vaginal maturation index and vaginal pH.

My notes (saved in your browser only)

MeSH descriptors

Female Urogenital Diseases Osteoporosis, Postmenopausal Raloxifene Hydrochloride Raloxifene Hydrochloride Vagina Vitamin D Vitamin D Bone Density Conservation Agents Bone Density Conservation Agents Bone Density Conservation Agents Drug Combinations Estrogen Replacement Therapy Female Female Urogenital Diseases Health Status Indicators Humans Hydrogen-Ion Concentration Hydrogen-Ion Concentration Middle Aged Osteoporosis, Postmenopausal

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (20)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:04:17.981133+00:00
License: CC0 · commercial use OK